The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain.
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
We were treated to some great new movies throughout January, but 2025 is only just getting started. With plenty more in the way of hotly anticipated films due to arrive in the months to come ...
A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...